David Bernstein
University of Cincinnati · Children's Hospital Medical Center, Cincinnati · Bernstein Clinical Research Center, LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Bernstein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:35 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04612803 · Antihistamines in the Treatment of Irritable Bowel Syndrome With DiarrheaUniversity of Cincinnati · withdrawn · Irritable Bowel Syndrome, Dermatographism, Post-prandial Diarrhea · principal investigator
- Ph1NCT03300050 · Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu VaccinePATH · completed · Influenza, Vaccine · principal investigator
- Ph2NCT03084718 · An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic SubjectsChiesi Farmaceutici S.p.A. · completed · Asthma · principal investigator
- Ph2/Ph3NCT02795273 · Efficacy and Safety of Grass-SPIRE Registration StudyCircassia Limited · withdrawn · Rhinitis, Conjunctivitis · principal investigator
- Ph1NCT02457286 · Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot StudyNorthwell Health · withdrawn · Non-alcoholic Fatty Liver Disease (NAFLD) · principal investigator
- Ph1/Ph2NCT01609257 · Norovirus Bivalent-Vaccine Efficacy StudyTakeda · completed · Prevention From Norovirus Infection · principal investigator
- Ph3NCT01471028 · Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver FailureVital Therapies, Inc. · completed · Acute Alcoholic Hepatitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Task A05: Small animal models for cytomegalovirus and herpes simplex viruses27220170001 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2018 to 2022 · $787,888 awarded in 2022Same name and institution; not confirmed by an ID
- Vaccine and Treatment Evaluation Units: Phase II Influenza Vaccine Clinical Trial27220130001 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2014 to 2019 · $195,030 awarded in 2019Same name and institution; not confirmed by an ID
- Immunology/Allergy Fellowship Training GrantT32AI060515 · NIAID · UNIVERSITY OF CINCINNATI · fiscal years 2004 to 2018 · $297,200 awarded in 2018Same name and institution; not confirmed by an ID
- Genetic Suceptibility for Occupational AsthmaR01OH008795 · NIOSH · UNIVERSITY OF CINCINNATI · fiscal years 2006 to 2016 · $360,717 awarded in 2016Same name and institution; not confirmed by an ID
- Task A85 Mouse and Guinea Pig Models for Herpesviruses27220100000 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2011 to 2016 · $754,237 awarded in 2016Same name and institution; not confirmed by an ID
- Vaccine and Treatment Evaluation Units27220080000 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2011 to 2012 · $300,000 awarded in 2012Same name and institution; not confirmed by an ID
- ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATIOON OF EXPERIMENTAL THERAPIEN01AI15438- · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2007 to 2010 · $506,233 awarded in 2010Same name and institution; not confirmed by an ID
- EVALUATION OF CONTROL MEASURES AGAINST DISEASES OTHER THAN AIDS-266025-266025459N01AI025459 · NIAID · CHILDREN'S HOSPITAL MEDICAL CE · fiscal years 2004 to 2006Same name and institution; not confirmed by an ID
- DNA vaccine effiicacy in Herpes Simplex Virus type 2R01AI047370 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2001 to 2003 · $296,000 awarded in 2003Same name and institution; not confirmed by an ID
- CHEMOKINE BIOMARKERS OF DIISOCYANATE OCCUPATIONAL ASTHMAR01OH003519 · NIOSH · UNIVERSITY OF CINCINNATI · fiscal years 1999 to 2002 · $349,622 awarded in 2002Same name and institution; not confirmed by an ID
- ANIMAL MODELS OF HUMAN VIRAL INFECTIONSN01AI065289 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 1999 to 2000 · $210,000 awarded in 2000Same name and institution; not confirmed by an ID
- IMMUNOBIOLOGY OF GENITAL HSV-2 INFECTIONR01AI023482 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 1987 to 1995 · $186,726 awarded in 1995Same name and institution; not confirmed by an ID
- IMMUNOPATHOGEN. OF OCCUP. DIS. DUE TO REACT. CHEMICALSK01OH000073 · NIOSH · UNIVERSITY OF CINCINNATI · fiscal years 1988 to 1991 · $32,400 awarded in 1991Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:35 UTC. The ranking covers the 200 most relevant of 238 PubMed records, and a shared surname and initials can bring in a namesake. All 238 on PubMed
- 971 citationsRCR 34.8
- The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.N Engl J Med · 1998734 citationsRCR 21.1
- Glycoprotein-D-adjuvant vaccine to prevent genital herpes.N Engl J Med · 2002609 citationsRCR 13.8
- ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.N Engl J Med · 2014583 citationsRCR 21.3
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.Hepatology · 2015522 citationsRCR 20.5
- Bivalirudin started during emergency transport for primary PCI.N Engl J Med · 2013420 citationsRCR 12.3
- Efficacy results of a trial of a herpes simplex vaccine.N Engl J Med · 2012410 citationsRCR 12.7
- A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.Am J Respir Crit Care Med · 2009400 citationsRCR 10.3
- Norovirus vaccine against experimental human Norwalk Virus illness.N Engl J Med · 2011376 citationsRCR 11.4
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.Cancer Discov · 2018376 citationsRCR 11.0